Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,488,812
  • Shares Outstanding, K 534,270
  • Annual Sales, $ 10,561 M
  • Annual Income, $ 717,000 K
  • 36-Month Beta 0.77
  • Price/Sales 3.62
  • Price/Cash Flow 18.25
  • Price/Book 4.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.74
  • Number of Estimates 8
  • High Estimate 0.75
  • Low Estimate 0.73
  • Prior Year 0.64
  • Growth Rate Est. (year over year) +15.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.19 +2.63%
on 08/15/18
76.51 -5.84%
on 07/25/18
-2.71 (-3.63%)
since 07/17/18
3-Month
70.19 +2.63%
on 08/15/18
76.51 -5.84%
on 07/25/18
+1.39 (+1.97%)
since 05/17/18
52-Week
60.53 +19.02%
on 08/21/17
76.51 -5.84%
on 07/25/18
+11.22 (+18.45%)
since 08/17/17

Most Recent Stories

More News
Boston Scientifc has the Best Relative Performance in the Health Care Equipment Industry (BSX , NUVA , BAX , EW , SYK )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

BSX : 34.41 (+0.35%)
NUVA : 69.96 (+1.91%)
BAX : 72.04 (+0.64%)
Recommended Cash Offer for Vernalis plc

LNSTY : 14.3700 (+1.63%)
MRK : 69.06 (+0.31%)
BK : 51.69 (+0.33%)
BAX : 72.04 (+0.64%)
NVS : 83.04 (+1.03%)
VNLPF : 0.2190 (unch)
AMGN : 197.42 (+0.50%)
BIIB : 345.22 (+0.67%)
Mallinckrodt (MNK) Beats on Q2 Earnings and Sales, Ups View

Mallinckrodt (MNK) surges following earnings and sales beat in the second quarter. Increase in annual guidance is impressive as well.

VRTX : 176.08 (+0.64%)
BAX : 72.04 (+0.64%)
SGEN : 74.64 (+0.58%)
MNK : 34.69 (+1.61%)
Global Adhesion Barriers Market 2018-2022 featuring Key Players Baxter International, BD, FzioMed, Johnson & Johnson, Medtronic, and Sanofi - ResearchAndMarkets.com

The "Global Adhesion Barriers Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

JNJ : 134.47 (+1.50%)
BAX : 72.04 (+0.64%)
MDT : 90.60 (-0.55%)
Abiomed Gets CDSCO Nod for Impella Heart Pumps in India

Abiomed's (ABMD) Impella gets regulatory approval in India; prospects in APAC look upbeat.

ABMD : 358.82 (-2.75%)
MASI : 113.81 (+0.26%)
BAX : 72.04 (+0.64%)
ISRG : 524.92 (+0.19%)
Watch for Baxter Intl Inc to Potentially Rebound After Falling 3.28% Yesterday

Baxter Intl Inc (NYSE:BAX) traded in a range yesterday that spanned from a low of $71.01 to a high of $75.00. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $74.65...

BAX : 72.04 (+0.64%)
Baxter (BAX) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Baxter (BAX) gains on the back of its core Renal Care segment in Q2; solid international sales encourage.

ITGR : 71.45 (+0.92%)
MASI : 113.81 (+0.26%)
BAX : 72.04 (+0.64%)
DVA : 72.49 (-0.52%)
Baxter (BAX) Beats on Q2 Earnings; Sales Meet Estimates

Baxter (BAX) gains from solid segmental performance in Q2.

BAX : 72.04 (+0.64%)
Baxter International (BAX) Surpasses Q2 Earnings and Revenue Estimates

Baxter (BAX) delivered earnings and revenue surprises of 8.45% and 0.21%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

BAX : 72.04 (+0.64%)
Baxter Reports Second-Quarter 2018 Results and Increases Earnings Outlook for Full-Year 2018

--Second-quarter GAAP earnings per share (EPS) of $0.63; Adjusted EPS of $0.77 increased 22 percent

BAX : 72.04 (+0.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade BAX with:

Business Summary

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare...

See More

Key Turning Points

2nd Resistance Point 72.83
1st Resistance Point 72.44
Last Price 72.04
1st Support Level 71.35
2nd Support Level 70.65

See More

52-Week High 76.51
Last Price 72.04
Fibonacci 61.8% 70.41
Fibonacci 50% 68.52
Fibonacci 38.2% 66.63
52-Week Low 60.53

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar